City of Hope Studies Offer Promising Data, Even Potential New Approaches To Hematologic Cancers

A new standard of care for HIV-associated lymphoma, promising news for patients with relapsing or treatment-resistant lymphoma, and immunotherapy approaches to treating hematologic cancers are among the breakthroughs City of Hope scientists will share at the American Society of Hematology meeting. Researchers from the Hematologic Malignancies and Stem Cell Transplantation Institute at City of Hope will share their findings at the annual ASH meeting in San Francisco from Dec. 6 to Dec. 9. More than 20,000 hematology professionals attend the annual conference, which highlights the hottest topics in the field.

http://ift.tt/1yJ8Nsd